An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis
NCT03573505
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
109
Enrollment
INDUSTRY
Sponsor class
Stopped
Study was stopped because of safety concerns.
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG:
BG00011
DRUG:
Placebo
Sponsor
Biogen